Concert in Chile had a COVID-19 infection rate of 0%, according to a clinical trial

The first clinical trial for the return of live music in Chile carried out at the end of August showed a contagion rate of 0%, according to confirmed this Tuesday its organizers, the Chilean Society of Musical Authors and Interpreters (SCD) and the Clinical Hospital of the University of Chile.

SIGHT: COVID-19 | Booster shot has similar side effects to the second dose

The results of the study called “Music rehearsals” were released after -, which was carried out with full capacity and safeguarding measures such as the use of masks and the requirement for full vaccination, concluded the clinical cycle with an exit PCR test.

“We are very satisfied with the results (…) This not only tells us that pandemic concerts can be held safely, with a mobility pass and permanent use of a mask, but it also shows us that the public wants and needs to return to live music, ye”said Rodrigo Osorio, President of SCD.

SIGHT: COVID-19 causes the biggest drop in life expectancy since World War II

The clinical report also indicated that an average room with full capacity could, with high probability, require additional ventilation mechanisms, an indication that will be incorporated for the second trial scheduled for October in the Chilean capital.

The immunologist from the University of Chile and scientist in charge of the study, Dr. Alejandro Afani, pointed out that depending on the objectives of the experiment, the measures will continue to be maintained as -document that proves complete vaccination-, but the PCR test will be replaced by a Antigen test for quick results.

SIGHT: Delta Plus variant of the coronavirus: More contagious and resistant to vaccines?

To date, in Chile 1.6 million people have been infected with SARS-CoV-2 and more than 45,000 have died, considering confirmed and suspected cases, according to the Department of Statistics and Information of the Minsal.

All in all, the country has developed one of the most successful inoculation campaigns in the world, reaching more than 88.3% of the target population – about 15 million people – with a full vaccination scheme.

• COVID-19 | Booster shot has similar side effects to the second dose
• COVID-19 causes the biggest drop in life expectancy since World War II
• COVID-19 | Pfizer will request authorization to administer its vaccine to children between 5 and 12 years of age in the United States.
• COVID-19 | Pfizer booster dose increased antibody levels 20 times in Sinovac vaccinated
• Pfizer Starts Human Trials of Messenger RNA Flu Vaccine
• Delta Plus variant of the coronavirus: More contagious and resistant to vaccines?
• COVID-19 | Patients who come to the ICU are mostly men and have more antibodies
• COVID-19 | Results of the Sinopharm clinical trial conducted in Peru will be “very soon”
• Sinopharm will be accepted to travel to the US: reasons to trust the Chinese vaccine
• What are “rogue” antibodies and what do they have to do with severe COVID-19?
• What will the third year of the pandemic be like ?, by Elmer Huerta
• COVID-19 | New Chinese vaccine is 79% effective against Delta variant
• COVID-19 May Look Like a Cold in the Future, AstraZeneca Developer Says
• Delta variant of COVID-19 is now predominant in Peru: five things you should know
• COVID-19 | Europe will decide in October whether to authorize Pfizer’s booster dose
• Sinopharm will be accepted to travel to the US: reasons to trust the Chinese vaccine
• COVID-19 | How close are we to the end of the pandemic?

Follow us on twitter:

!function(d,s,id){var js,fjs=d.getElementsByTagName(s)[0],p=/^http:/.test(d.location)?’http’:’https’;if(!d.getElementById(id)){js=d.createElement(s);js.id=id;js.src=p+’://platform.twitter.com/widgets.js’;fjs.parentNode.insertBefore(js,fjs);}}(document, ‘script’, ‘twitter-wjs’);

.

Deshawn